GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bicara Therapeutics Inc (NAS:BCAX) » Definitions » Tax Rate %

BCAX (Bicara Therapeutics) Tax Rate % : 0.00% (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Bicara Therapeutics Tax Rate %?

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. Bicara Therapeutics's Tax Expense for the three months ended in Sep. 2024 was $0.00 Mil. Bicara Therapeutics's Pre-Tax Income for the three months ended in Sep. 2024 was $-17.48 Mil. Therefore, Bicara Therapeutics's Tax Rate % for the quarter that ended in Sep. 2024 was 0.00%.


Bicara Therapeutics Tax Rate % Historical Data

The historical data trend for Bicara Therapeutics's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bicara Therapeutics Tax Rate % Chart

Bicara Therapeutics Annual Data
Trend Dec22 Dec23
Tax Rate %
- -0.01

Bicara Therapeutics Quarterly Data
Dec22 Jun23 Sep23 Dec23 Jun24 Sep24
Tax Rate % Get a 7-Day Free Trial - - -0.04 - -

Bicara Therapeutics Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

Bicara Therapeutics's Tax Rate % for the fiscal year that ended in Dec. 2023 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2023 )/Pre-Tax Income (A: Dec. 2023 )
=0.005/-51.98
=-0.01 %

Bicara Therapeutics's Tax Rate % for the quarter that ended in Sep. 2024 is calculated as

Tax Rate %=Tax Expense (Q: Sep. 2024 )/Pre-Tax Income (Q: Sep. 2024 )
=0/-17.481
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bicara Therapeutics Tax Rate % Related Terms

Thank you for viewing the detailed overview of Bicara Therapeutics's Tax Rate % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bicara Therapeutics Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
116 Huntington Avenue, Suite 703, Boston, MA, USA, 02116
Website
Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.